The U.S. Food and Drug Administration (FDA) has approved a more gradual titration dosing schedule for Kisunla (donanemab) for…
Articles by Lindsey Shapiro, PhD
Leqembi (lecanemab) has won marketing authorization in the European Union for the treatment of certain adults with early…
Age at menopause may interact with factors related to the health of synapses, or nerve cell connections, to influence the…
The U.S. Food and Drug Administration (FDA) has approved Eli Lilly‘s antibody therapy donanemab, now Kisunla, for certain…
The U.S. Food and Drug Administration (FDA) has lifted a clinical hold on a Phase 2 trial testing INmune…
The U.S. Food and Drug Administration (FDA) has approved BrainSee, Darmiyan’s software for predicting the likelihood that a person…
A tool called focused ultrasound, or FUS, may be a safe and promising way to help antibody-based treatments better reach…
With November comes National Alzheimer’s Awareness Month, an annual effort to recognize the impact of the neurodegenerative disease in…
An ongoing Phase 2/3 clinical trial testing Annovis Bio’s treatment candidate buntanetap in people with Alzheimer’s disease is…
Anavex Life Sciences’ investigational oral therapy Anavex 2-73 (blarcamesine) significantly slows cognitive and functional decline in people with…